Bioinformatics Core for PDx Data and Analysis
Official title: Bioinformatics Core
Funded at Wistar Institute · NIH-11397802 · Data updated 2026-11-12
A Bioinformatics Core at Wistar helps analyze and securely store complex cancer data so researchers can learn from many experiments and share results.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wistar Institute NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | September 1, 2017 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $61,466 |
| NIH project number | 5U54CA224070-08 |
| Project ID | NIH-11397802 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable for this core grant itself; however, the work supports PDTC cancer research that may involve patient-derived data and future trials.
✕Less likely to help
Direct patient benefit is not the primary aim of this core grant.
What this research studies
This core provides bioinformatics and statistical analyses on data produced by multiple projects, and it combines results across experiments for clearer insights. It also manages central storage and information security for large-scale data from PDX trials. The team assists with writing progress reports, abstracts, manuscripts, and future proposals. Timely progress tracking and sharing results among PDTC members are key goals during the grant period.
Why it matters
Potential benefit: If successful, patients could benefit from faster, more integrated insights from cancer research and improved data security around their samples.
How similar studies have gone: Bioinformatics cores with centralized storage and integrative analyses have accelerated cancer research and data sharing in comparable programs.
Where this research is happening
-
Wistar Institute
Philadelphia, United States Active
Researchers
- Principal investigator: Kossenkov, Andrew V — Wistar Institute
- Study coordinator: Kossenkov, Andrew V
Related research
Other NIH-funded projects on the same topics.
-
Immunomodulation to Fight Cancer Spread
A cancer-focused training opportunity to learn how tumors and the immune system interact during cancer spread and use that knowledge to develop new immunotherapies.
-
Broadly neutralizing nanobodies to improve HIV therapy
Researchers are developing tiny antibodies called nanobodies to target HIV in new ways that could make treatments easier and more effective for people living with HIV.
-
BEAT-HIV: a collaborative effort to cure HIV with immunotherapy
A multi-institution study is testing a combination immunotherapy approach to achieve long-term HIV remission or cure for people on ART.
-
Epitope-engineered stem cells to enable HIV cure with targeted CAR-T therapy
A patient-focused plan to use a person’s own stem cells, edited to resist HIV and paired with specialized CAR-T cells, to clear HIV reservoirs.
-
Comprehensive bioinformatics support for cancer research at a leading cancer center
A cancer center-wide bioinformatics program helps researchers analyze data, build reusable data resources, and apply computational methods to cancer studies.
-
Refocusing HIV antibodies to target parts that block many strains
This project tries a new vaccine approach to steer the immune system to make antibodies that can block many types of HIV for people at risk.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.